Results of implementation of a 'Complex of measures to improve medical care for patients with stroke in the Russian Federation'
Authors:
- V. I. SkvortsovaVSV. I. Skvortsova
- I. M. ShetovaISI. M. Shetova
- E. P. KakorinaEKE. P. Kakorina
- E. G. KamkinEKE. G. Kamkin
- E. L. BoikoEBE. L. Boiko
- B. G. AlekyanBAB. G. Alekyan
- G. E. IvanovaGIG. E. Ivanova
- N. A. ShamalovNSN. A. Shamalov
- V. G. DashyanVDV. G. Dashyan
- V. V. KrylovVKV. V. Krylov
- 1 January 2018
- journal article
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 118 (4) , 5-12
Abstract
Medical article медицинская статьяKeywords
This publication has 17 references indexed in Scilit:
- Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in StrokeNew England Journal of Medicine, 2015
- Thrombectomy within 8 Hours after Symptom Onset in Ischemic StrokeNew England Journal of Medicine, 2015
- Randomized Assessment of Rapid Endovascular Treatment of Ischemic StrokeNew England Journal of Medicine, 2015
- Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging SelectionNew England Journal of Medicine, 2015
- A Randomized Trial of Intraarterial Treatment for Acute Ischemic StrokeNew England Journal of Medicine, 2015
- Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010The Lancet Global Health, 2013
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeNew England Journal of Medicine, 2008
- Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom OnsetJAMA, 1999
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)The Lancet, 1998
- Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric StrokeJAMA, 1995